Results 211 to 220 of about 81,312 (294)

Trente ans de décentralisation de l’action sociale dans Dossier Trente ans de décentralisation [PDF]

, 2012
H. Rihal
core   +1 more source

Introducing AI & Innovation

AI &Innovation, EarlyView.
Mirko Farina, Xiao Yu, Rongrong Ji, Chen Jin, Vincent Blok, Paolo Ciancarini, Ngcaweni Busani, Witold Pedrycz   +7 more
wiley   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Understanding stakeholder perspectives on integrating and sustaining a vertical HIV prevention programme into routine health services in Zimbabwe: a qualitative study. [PDF]

BMJ Glob Health
Chung AM, Murungu J, Case P, Chitapi P, Chikodzore R, Gosling J, Xaba S, Ncube G, Mugurungi O, Kunaka P, Prata N, Gosling RD, Bertozzi SM, Auerswald C.   +13 more
europepmc   +1 more source

Décentralisation [PDF]

Giappiconi, Thierry
core  

Agreement of treatment effects in decentralised trials versus traditional trials: meta-epidemiological study.

BMJ
Chaboud L, Janiaud P, Hirt J, Hemkens LG.   +3 more
europepmc   +1 more source

Diagnostic accuracy of the WHO tuberculosis treatment decision algorithms for children with presumptive tuberculosis: An individual participant data meta-analysis. [PDF]

PLoS Med
Olbrich L, Larsson L, Dunbar R, Dodd PJ, Palmer M, Huyen Ton Nu Nguyet M, d'Elbée M, Hesseling AC, Heinrich N, Zar HJ, Ntinginya NE, Khosa C, Nliwasa M, Verghese VP, Bonnet M, Wobudeya E, Nduna B, Moh R, Mwanga-Amumpere J, Mustapha A, Breton G, Taguebue JV, Borand L, Chabala C, Marcy O, Seddon JA, van der Zalm MM, Decide-TB Study Group, the RaPaed-TB Consortium, the Umoya Study Group, and the TB Speed Consortium.   +30 more
europepmc   +1 more source

More with Less? Fiscal Decentralisation, Public Health Spending and Health Sector Performance

, 2017
H. Arends
semanticscholar   +1 more source

Through the lens of marketing authorization holders: experience in use of real‐world data and real‐world evidence in drug development and regulatory submissions in EU

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this study was to assess the general and product‐specific experiences of MAHs use of RWD/RWE in medicines development and in their regulatory submissions, and to explore organizational aspects of MAHs related to RWD/RWE. Methods An electronic survey was conducted, and information collected directly from MAHs.
Sini M. Eskola, Aleksandar Gigov, Hubertus G. M. Leufkens, Andrew Bate, Marie Louise De Bruin, Helga Gardarsdottir   +5 more
wiley   +1 more source

Références bibliographiques du dossier « Les grands débats éducatifs aujourd’hui »

Revue Internationale d’Éducation de Sèvres, 1997
Maryannick Vervisch-Lestrade
doaj   +1 more source